TNBC - Triple-Negative Breast Cancer

Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
olaparibPhase 21 trial
Active Trials
NCT05209529Withdrawn0Est. Jul 2030
Arcus Biosciences
1 program
1
EtrumadenantPhase 11 trial
Active Trials
NCT03719326CompletedEst. Jul 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
AstraZenecaolaparib
Arcus BiosciencesEtrumadenant

Clinical Trials (2)

NCT05209529AstraZenecaolaparib

Chemo-free BRCA-targeted Neoadjuvant Strategy

Start: Feb 2024Est. completion: Jul 20300
Phase 2Withdrawn
NCT03719326Arcus BiosciencesEtrumadenant

A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies

Start: Oct 2018Est. completion: Jul 2021
Phase 1Completed

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
5m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
5m ago

Office Administrator

SystImmune
5m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
16m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
19m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
19m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)